GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178,740 | -16.6% | 3,600 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $214,344 | -22.8% | 3,600 | -26.5% | 0.00% | -20.0% |
| Q1 2023 | $277,536 | -23.7% | 4,900 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $363,923 | +24.6% | 4,900 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $292,000 | +6.2% | 4,900 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $275,000 | -24.0% | 4,900 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $362,000 | +2.3% | 4,900 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $354,000 | -13.7% | 4,900 | -8.4% | 0.01% | -12.5% |
| Q3 2021 | $410,000 | -1.2% | 5,352 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $415,000 | +37.4% | 5,352 | +9.2% | 0.01% | +14.3% |
| Q1 2021 | $302,000 | -5.6% | 4,900 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $320,000 | +31.7% | 4,900 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $243,000 | +3.8% | 4,900 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $234,000 | +12.5% | 4,900 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $208,000 | -28.0% | 4,900 | 0.0% | 0.01% | -12.5% |
| Q4 2019 | $289,000 | – | 4,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |